Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
If you need immediate assistance, call 877-SSRNHelp (877 777 6435) in the United States, or +1 212 448 2500 outside of the United States, 8:30AM to 6:00PM U.S. Eastern, Monday - Friday.
Jiyan Liu
Sichuan University - Department of Medical Oncology
No 37, Guoxue Road
Wuhou District
Chengdu, 610041
China
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
70
SSRN CITATIONS
0
CROSSREF CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Efficacy and Safety of RC48-ADC, a Her2-Targeting Antibody-Drug Conjugate, in Patients with Locally Advanced or Metastatic Urothelial Carcinoma: A Phase 2, Open-Label, Multi-Centre, Single-Arm Study
Number of pages: 118
Posted: 02 Oct 2019
Xinan Sheng
,
Xieqiao Yan
,
Lin Wang
,
Yanxia Shi
,
Xin Yao
,
Hong Luo
,
Benkang Shi
, Jiyan Liu,
Zhisong He
,
Guohua Yu
,
Jianming Ying
,
Weiqing Han
,
Changlu Hu
,
Yun Ling
,
Zhihong Chi
,
Chuanliang Cui
,
Lu Si
,
Jianmin Fang
,
Aiping Zhou
and
Jun Guo
Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Chinese Academy of Medical Sciences - State Key Lab of Molecular Oncology, Sun Yat-sen University (SYSU) - Department of Medical Oncology, Tianjin Medical University, Chongqing University, Shandong University - Qilu Hospital, Sichuan University - Department of Medical Oncology, Peking University - Department of Urology, Government of the People's Republic of China - Weifang No. 2 People's Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Pathology, Central South University - Affiliated Cancer Hospital, Anhui Provincial Cancer Hospital, Chinese Academy of Medical Sciences - National Cancer Center, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, RemeGen, Ltd., Chinese Academy of Medical Sciences - State Key Lab of Molecular Oncology and Peking University - Key Laboratory of Carcinogenesis and Translational Research
Downloads
70
(446,934)
View PDF
Download
Abstract:
Feedback